A ruthenium catalyst facilitated the polymerization, or polymer addition. Industrial firms have used this catalyst to make ...

New research adds to our understanding of the function of the human genome. An international team of researchers has made ...

Beam Therapeutics Inc. (NASDAQ:BEAM), a biotechnology company at the forefront of precision genetic medicines with a market capitalization of $1.87 billion, is navigating a critical juncture in its ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

In a few decades, gene-editing technologies could reduce the likelihood of common human diseases. Societies must use this ...

Nebraska researchers introduce Minovacca, pioneering programmable milk exosomes for targeted therapeutic delivery, offering ...

Baby with genetic OTC deficiency shows promising response to iECURE's first-in-kind gene therapy, potentially avoiding liver ...

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...

Seed gene-editing startup Inari has completed a $144 million Series G round, bringing its cumulative funding to $720 million.

I recently watched an episode of one of my favourite TV shows, the Good Doctor. The episode revolved around how a man named Wyatt was rushed into the ER as he had a perforated valve and needed ...

UK ministers are pressing ahead with legislation to adopt gene editing technology despite warnings from Brussels that it ...